Atherosclerosis in Rheumatoid Arthritis
Completed
Conditions studied: Rheumatoid Arthritis, Endothelial Dysfunction
In brief
The purpose of this study is to investigate the link between rheumatoid arthritis and cardiovascular disease by studying inflammation, joint disease, cholesterol abnormalities, and endothelial function.
Key facts
- Study ID
- NCT00990730
- Run by
- University of California, San Francisco
- People needed
- 80
- Starts
- 2009-09-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2012-01-25
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of RA by ACR criteria
- Age 18-80
- Enrolled in UCSF RA cohort already
You may not qualify if…
- Diabetes (on meds or in medical history)
- Pregnant or Lactating
- Renal failure (Creatinine > 2mg/dL or on dialysis)
- History of MI or CAD
- History of ischemic CVA
- Symptomatic PVD
- Current uncontrolled hypertension (blood pressure > 160/100mmHg)
- Daily prednisone > 10mg daily
- Current smoker
- New BP med within 3 months
- New statin within 3 months
- Change in RA meds: new or increase in prednisone within 1 month, new TNF inhibitor within 2 months, titration of methotrexate, leflunomide or sulfasalazine within 3 months.
Where it is running
- UCSF San Francisco General Hospital Vascular Research Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.